Xodus Medical is projected to deliver USD 245.00 million revenue in 2026. For STERIS stock, closing

STERIS signed a definitive agreement to acquire Xodus Medical, a Pennsylvania-based specialty surgical products company focused on patient and operating room staff safety, for $2.1 billion at closing.

Xodus focuses on products that make surgery safer; STERIS says the deal would add operating-room supplies and reports 18,000 associates.

Consumable product portfolio a natural extension for STERIS’s Healthcare CustomersCompelling financial benefits: expected to be accretive to top-line growth, margins and adjusted earnings Anticipated to close by December 31, 2026 DUBLIN, IRELAND, Oct. 12, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that STERIS Corporation, a wholly owned subsidiary of the Company, has signed a definitive agreement to acquire Xodus Medical, Inc., a specialty surgica

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

STERIS stock costs EUR 186.55 on October 8, 2026 after EUR 187.30. First-quarter fiscal 2027 revenue